CIBC Bancorp USA’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.85M Buy
499,912
+197,924
+66% +$856K ﹤0.01% 882
2026
Q1
$1.17M Buy
+301,988
New +$1.24M ﹤0.01% 1018
2025
Q3
$52.6K Buy
+15,991
New +$45.1K ﹤0.01% 1411

Other funds holding PGEN

CIBC Bancorp USA's PGEN Position: Q2 2026 in Review

CIBC Bancorp USA increased its Precigen (PGEN) stake by 66% in Q2 2026, buying an estimated $856K and bringing the position to 499,912 shares worth $2.85M. The position accounts for ﹤0.01% of the portfolio, ranked #882.

CIBC Bancorp USA first reported a position in PGEN in Q3 2025 and has held it in 3 quarters since. 197 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • CIBC Bancorp USA held 499,912 shares of Precigen worth $2.85M as of Q2 2026.
  • CIBC Bancorp USA bought 197,924 Precigen shares in Q2 2026, an estimated $856K.
  • Precigen made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #882 holding.
  • CIBC Bancorp USA first reported a position in Precigen in Q3 2025 and has held it in 3 quarters since.
  • 197 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.